Review



goat anti mouse  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Bio-Rad goat anti mouse
    Goat Anti Mouse, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 522 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti mouse/product/Bio-Rad
    Average 95 stars, based on 522 article reviews
    goat anti mouse - by Bioz Stars, 2026-06
    95/100 stars

    Images



    Similar Products

    94
    Cell Signaling Technology Inc mousespecific monoclonal antibody against egfr
    Mousespecific Monoclonal Antibody Against Egfr, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mousespecific monoclonal antibody against egfr/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    mousespecific monoclonal antibody against egfr - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc akt
    A Top: EREG , AREG , <t>and</t> <t>EGFR</t> mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, <t>phospho-Akt,</t> phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Akt, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/akt/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    akt - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc phospho egfr y1068
    A Top: EREG , AREG , <t>and</t> <t>EGFR</t> mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, <t>phospho-Akt,</t> phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Phospho Egfr Y1068, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/phospho egfr y1068/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    phospho egfr y1068 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc egf receptor mouse mab
    A Top: EREG , AREG , <t>and</t> <t>EGFR</t> mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, <t>phospho-Akt,</t> phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Egf Receptor Mouse Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/egf receptor mouse mab/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    egf receptor mouse mab - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    95
    Bio-Rad goat anti mouse
    A Top: EREG , AREG , <t>and</t> <t>EGFR</t> mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, <t>phospho-Akt,</t> phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Goat Anti Mouse, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti mouse/product/Bio-Rad
    Average 95 stars, based on 1 article reviews
    goat anti mouse - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    Bio-Rad goat anti mouse antibodies
    A Top: EREG , AREG , <t>and</t> <t>EGFR</t> mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, <t>phospho-Akt,</t> phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Goat Anti Mouse Antibodies, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti mouse antibodies/product/Bio-Rad
    Average 95 stars, based on 1 article reviews
    goat anti mouse antibodies - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti pho egfr
    A Top: EREG , AREG , <t>and</t> <t>EGFR</t> mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, <t>phospho-Akt,</t> phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Anti Pho Egfr, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti pho egfr/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti pho egfr - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    Image Search Results


    A Top: EREG , AREG , and EGFR mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, phospho-Akt, phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

    Journal: Oncogene

    Article Title: Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumourigenesis by non-canonical activation of a GLI-PI3K loop

    doi: 10.1038/s41388-026-03698-9

    Figure Lengend Snippet: A Top: EREG , AREG , and EGFR mRNA expression in SCR, C9, and C15 cells by qPCR. Expression levels were normalized to GAPDH mRNA and represented as fold change relative to control SCR cells ( n = 3). Bottom: expression of the same genes in pooled RNA from xenografts derived from SCR and C9 cells. B Representative western blot of EGFR, phospho-Akt, phospho-ERK1/2, total Akt, total ERK1/2, and GADPH in SCR, C9, and C15 cells. C Effect of 10 μM Erlotinib or vehicle control on cell proliferation of SCR, C9 and C15 cells over time ( n = 3). D . Effect of 10 μM Erlotinib or vehicle control (DMSO) on the colony formation ability of SCR, C9 and C15 cells upon culture for 10 days. Left: representative images at the end of the experiment. Right: number of colonies per 1,000 plated cells at day 10 ( n = 3). E Effect of 10 μg/ml Cetuximab or a control IgG on the cell number of SCR, C9 and C15 cells after 72 h treatment ( n = 3). F Effect of 30 nM Trametinib or DMSO vehicle on phospho-ERK1/2 levels in SCR, C9 and C15 cells. G Dose dependent reduction of cell proliferation in SCR, C9, and C15 cells treated with Trametinib for 72 h ( n = 3). All quantitative data represent the mean ± SEM of independent biological repeats (indicated n), performed in technical replicates. ns = not significant; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

    Article Snippet: The following antibodies were used: EGFR (Cell Signaling Technology #2256, WB 1:1,000), AKT (Cell Signaling Technology #4691, WB 1:1,000), phospho- AKT (Ser473) (D9E) XP (Cell Signaling Technology #5012, WB 1:1,000), p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (Cell Signaling Technology #4695, WB 1:1,000), phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (Cell Signaling Technology #4376, WB 1:1,000), Gli1 (Cell Signaling Technology #2643, WB 1:1,000), Phospho-PKA substrate (Cell Signaling Technology #9624, WB 1:1,000), GAPDH-HRP (Proteintech #HRP-60004, WB 1:3,000), Vinculin (Santa Cruz #sc-73614, WB 1:10,000), Poly-ADP ribose Polymerase (Cell Signaling Technology #9542, WB 1:2,000), anti VP16 (Santa Cruz #sc7545, WB 1:1,000),HA-Tag (Invitrogen #26183, WB 1:10,000), goat anti-rabbit IgG HRP (BioRad #172-1019, WB 1:3,000), goat anti-mouse IgG (H L)-HRP conjugate (Bethyl #A90-116P, WB 1:3,000).

    Techniques: Expressing, Control, Derivative Assay, Western Blot